Clinical relevance and practical implications of trials of perfusion and angiographic imaging in patients with acute ischaemic stroke: A multicentre cohort imaging study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 9, 2013, Pages 1001-1007

  Wardlaw, Joanna M ^a,d   Muir, Keith W ^b   Macleod, Mary Joan ^c   Weir, Christopher ^a   McVerry, Ferghal ^b   Carpenter, Trevor ^a   Shuler, Kirsten ^a   Thomas, Ralph ^a   Acheampong, Paul ^c   Dani, Krishna ^b   Murray, Alison ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN REGION; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; VASCULAR PATENCY;

EID: 84881556404     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304807     Document Type: Article

References (36)

1. Ebinger M, Christensen S, De Silva DA, et al. Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke 2009;40:1353-8.
2. Rha J, Saver JL. The impact of recanalization on ischemic stroke outcome. A meta-analysis. Stroke 2007;38:967-73. (Pubitemid 46568460)
3. Davis SM, Donnan G, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled radomised trial. Lancet Neurol 2008;7:299-309.
4. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis. A meta-analysis. Stroke 2010;41:e25-33.
5. Soares BP, Chien JD, Wintermark M. MT and CT monitoring of recanalization, reperfusion, and penumbra salvage. Everything that recanalizes does not necessarily reperfuse! Stroke 2009;40:S24-7.
6. Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005;76:1528-33. (Pubitemid 41531700)
7. Dani KA, Thomas RGR, Chappell FM, et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol 2011;70:384-401.
8. Kane I, Carpenter T, Chappell F, et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke. Effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007;38:3158-64. (Pubitemid 350175730)
9. Dani KA, Thomas RG, Chappell FM, et al. Systematic review of perfusion imaging with computed tomography and magnetic resonance in acute ischemic stroke: heterogeneity of acquisition and postprocessing parameters: a Translational Medicine Research Collaboration multicentre acute stroke imaging study. Stroke 2012;43:563-6.
10. De Silva DA, Fink JN, Christensen S, et al. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke 2009;40:2872-4.
11. Wilson JT, Hareendran A, Hendry A, et al. Reliability of the modified Rankin Scale across multiple raters: benefits of a structured interview. Stroke 2005;36:777-81.
12. Barber PA, Demchuk AM, Zhang J, et al. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4. (Pubitemid 30248478)
13. Rodríguez González D, Carpenter T, van Hemert JI, et al. An open source toolkit for medical imaging de-identification. Eur Radiol 2010;20:1896-904.
14. Carpenter T, Armitage PA, Bastin ME, et al. DSC perfusion MRI-quantification and reduction of systematic errors arising in areas of reduced cerebral blood flow. Magn Reson Med 2006;55:1342-9. (Pubitemid 43856772)
15. Wu O, Ostergaard L, Weisskoff RM, et al. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164-74. (Pubitemid 36841872)
16. Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. Stroke 2008;39:1621-8.
17. Wardlaw JM, Sellar RJ. A simple practical classification of cerebral infarcts on CT and its interobserver reliability. AJNR Am J Neuroradiol 1994;15:1933-9. (Pubitemid 24352841)
18. Wardlaw JM, von Kummer R, Farrall AJ, et al. A large web-based observer reliability study of early ischaemic signs on computed tomography. The Acute Cerebral CT Evaluation Of Stroke Study (ACCESS). PLoS ONE 2010;5:e15757.
19. Kharitonova T, Thoren M, Ahmed N, et al. Disappearing hyperdense middle cerebral artery sign in ischemic stroke patients treated with intravenous thrombolysis-clinical course and prognostic significance. J Neurol Neurosurg Psychiatry 2008;80:273-8.
20. van Swieten JC, Hijdra A, Koudstaal PJ, et al. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990;53:1080-3.
21. Farrell C, Chappell F, Armitage PA, et al. Development and initial testing of normal reference MR images for the brain at ages 65-70 and 75-80 years. Eur Radiol 2008;19:177-83.
22. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-82.
23. Arnold M, Nedeltchev K, Remonda L, et al. Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical functional outcome. J Neurol Neurosurg Psychiatry 2005;76:1373-6. (Pubitemid 41360974)
24. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6.
25. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
26. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485-91.
27. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2008;8:141-50.
28. Chemmanam T, Campbell BC, Christensen S, et al. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010;75:1040-7.
29. Luby M, Ku KD, Latour LL, et al. Visual perfusion-diffusion mismatch is equivalent to quantitative mismatch. Stroke 2011;42:1010-14.
30. Thomas RGR, Lymer GKS, Armitage PA, et al. Apparent diffusion coefficient thresholds and diffusion lesion volume in acute stroke. J Stroke Cerebrovasc Dis. Published Online First: 24 November 2012. doi: 10.1016/j. jstrokecerebrovasdis. 2012.09.018
31. Puetz V, Dzialowski I, Hill MD, et al. The Alberta Stroke Program Early CT Score in clinical practice: what have we learned? Int J Stroke 2009;4:354-64.
32. Khatri P, Neff J, Broderick JP, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-3. (Pubitemid 41566966)
33. Wardlaw JM, von Kummer R, Carpenter T, et al. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six hours of acute ischaemic stroke. Int J Stroke 2013. doi: 10.1111/j.1747-4949.2012.00946.x
34. Nabavi DG, Kloska SP, Nam EM, et al. MOSAIC: Multimodal Stroke Assessment Using Computed Tomography: novel diagnostic approach for the prediction of infarction size and clinical outcome. Stroke 2002;33:2819-26. (Pubitemid 35462850)
35. The IST-3 Collaborative Group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379:2352-63.
36. Lansberg MG, Lee J, Christensen S, et al. RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke 2011;42:1608-14.